# A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010

> **NCT03311373** · PHASE1 · COMPLETED · sponsor: **Pearl Therapeutics, Inc.** · enrollment: 56 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** Regimen A
- **DRUG:** Regimen B
- **DRUG:** Regimen C
- **DRUG:** Regimen D

## Key facts

- **NCT ID:** NCT03311373
- **Lead sponsor:** Pearl Therapeutics, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-10-17
- **Primary completion:** 2017-12-15
- **Final completion:** 2017-12-15
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2020-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03311373

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03311373, "A Randomized, Open-label, Single-dose, Single-center, Crossover Study in Healthy Subjects to Assess the Relative Bioavailability of PT010". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03311373. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*